Total Funding
28
65
Total FundingFunding Round raised
Growth Score
-4 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
227233
CSFRefresh develops a safe and effective treatment for Alzheimer’s disease by improving the removal of AD toxins from the brain.
About the Company
CSFRefresh develops a safe and effective treatment for Alzheimer’s disease by improving the removal of AD toxins from the brain. It is developing a novel biomedical device, a patent-pending “smart”, self-regulating cerebrospinal fluid (CSF) shunt capable of improving the CSF circulation. Increasing the CSF turnover rate, the rate at which the CSF
volume is replaced each day will clear toxic metabolites from the brain, e.g, amyloid-beta peptide (Aβ) and phospho-tau (pTau) that cause AD. Normal CSF turnover is 4-5 volumes/day. In AD and NPH it is reduced to once/day.
